SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0001104659-12-042614
Filing Date
2012-06-08
Accepted
2012-06-08 16:47:34
Documents
11
Period of Report
2012-03-31
Filing Date Changed
2012-06-08

Document Format Files

Seq Description Document Type Size
1 10-Q a12-9428_110q.htm 10-Q 689214
2 EX-31.1 a12-9428_1ex31d1.htm EX-31.1 10670
3 EX-31.2 a12-9428_1ex31d2.htm EX-31.2 10653
4 EX-32.1 a12-9428_1ex32d1.htm EX-32.1 6788
5 EX-32.2 a12-9428_1ex32d2.htm EX-32.2 6807
  Complete submission text file 0001104659-12-042614.txt   2631077

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT supn-20120331.xml EX-101.INS 263075
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT supn-20120331.xsd EX-101.SCH 10839
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT supn-20120331_cal.xml EX-101.CAL 46279
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT supn-20120331_def.xml EX-101.DEF 83384
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT supn-20120331_lab.xml EX-101.LAB 252215
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT supn-20120331_pre.xml EX-101.PRE 118969
Mailing Address 1550 E GUDE DR ROCKVILLE MD 20850
Business Address 1550 E GUDE DR ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS INC (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-35518 | Film No.: 12898362
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1